Stryker Unsuccessful in KFx Medical Patent Challenge
The U.S. Patent Trial and Appeal Board denied Stryker's request for an inter partes review of challenged claims in a suit pertaining to KFx Medical's suture anchors. Sep 18, 2019
Royal Biologics Launches Maxx Ultra Cord in the U.S.
Royal Biologics commenced U.S. commercial launch of Maxx Ultra Cord, a maximum natural thickness allograft derived from umbilical cord. Sep 17, 2019
TheraCell Announces Milestone Delivery of >12,000 of its Licensed Bone Grafts
TheraCell announced the delivery of over 12,000 of its licensed novel demineralized bone fiber products, primarily for use in spinal fusions. Sep 17, 2019
DiscGenics’ U.S. Clinical Study of Cell Therapy for Disc Degeneration Passes Halfway Mark
The first 30 patients received treatment in DiscGenics' first-in-human U.S. clinical study of IDCT injectable disc cell therapy for mild to moderate degenerative disc disease. Sep 16, 2019
Zimmer Biomet Receives FDA Clearance of JuggerStitch Meniscal Repair
Zimmer Biomet was granted FDA 510(k) clearance for the JuggerStitch device for meniscal repair. Sep 16, 2019
Orthoscan Launches Mini C-arm for Pediatric Applications
Orthoscan launched the TAU family of mini C-arms, designed and approved for use with pediatric patients. Sep 16, 2019
X-BOLT Hip Fixation Shows 0.8% Reoperation Rate in Study
Preliminary study results indicate that X-BOLT Orthopaedics' X-BOLT device for hip fracture repair demonstrated a cut-out rate of 0.8% in a population of 476 patients, and performed as well as a hip sliding screw in measures such as quality of life, mortality, revision, etc. Sep 13, 2019
Wright Medical Completes Enrollment in U.K. INFINITY Ankle Study
Wright Medical completed enrollment of 500 patients in its U.K.-based postmarket INFINITY Total Ankle follow-up study. Sep 12, 2019
Cellular Biomedicine Launching AlloJoin Knee OA Phase II Clinical Trial
Cellular Biomedicine launched a Phase II clinical trial for AlloJoin® allogenic mesenchymal progenitor cell therapy in the treatment of knee osteoarthritis. Sep 12, 2019
Camber Spine Launches SPIRA-O Open Matrix Interbody
Camber Spine launched the SPIRA-O® Open Matrix OLIF device in the U.S. Sep 12, 2019
